Brokerages expect that ProAssurance Co. (NYSE:PRA) will post $217.62 million in sales for the current quarter, Zacks reports. Three analysts have provided estimates for ProAssurance’s earnings, with estimates ranging from $215.48 million to $219.09 million. ProAssurance posted sales of $207.91 million in the same quarter last year, which suggests a positive year over year growth rate of 4.7%. The company is expected to issue its next earnings report on Thursday, May 3rd.

According to Zacks, analysts expect that ProAssurance will report full-year sales of $217.62 million for the current financial year, with estimates ranging from $872.22 million to $888.68 million. For the next financial year, analysts expect that the company will post sales of $910.60 million per share, with estimates ranging from $886.57 million to $929.33 million. Zacks’ sales averages are an average based on a survey of analysts that that provide coverage for ProAssurance.

How to Become a New Pot Stock Millionaire

ProAssurance (NYSE:PRA) last announced its quarterly earnings data on Wednesday, February 21st. The insurance provider reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.62 by ($0.07). The business had revenue of $209.12 million during the quarter, compared to analysts’ expectations of $217.03 million. ProAssurance had a return on equity of 6.11% and a net margin of 12.38%. The firm’s revenue was down 12.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.83 earnings per share.

Several brokerages recently issued reports on PRA. TheStreet downgraded ProAssurance from a “b” rating to a “c+” rating in a research note on Friday, March 9th. Keefe, Bruyette & Woods reissued a “hold” rating and issued a $55.00 price objective on shares of ProAssurance in a research note on Tuesday, February 27th. Zacks Investment Research downgraded ProAssurance from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. Boenning Scattergood reissued a “hold” rating on shares of ProAssurance in a research note on Thursday, February 22nd. Finally, Raymond James Financial raised ProAssurance from an “underperform” rating to a “market perform” rating in a research note on Wednesday, February 28th. Two research analysts have rated the stock with a sell rating and four have issued a hold rating to the company’s stock. ProAssurance has an average rating of “Hold” and a consensus target price of $57.33.

In other news, CEO William Stancil Starnes sold 25,896 shares of the firm’s stock in a transaction dated Friday, January 12th. The stock was sold at an average price of $55.01, for a total transaction of $1,424,538.96. Following the completion of the sale, the chief executive officer now directly owns 277,772 shares of the company’s stock, valued at approximately $15,280,237.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold a total of 39,074 shares of company stock valued at $2,149,329 over the last ninety days. Company insiders own 1.80% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of ProAssurance by 50.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,109 shares of the insurance provider’s stock worth $178,000 after purchasing an additional 1,042 shares in the last quarter. Everence Capital Management Inc. purchased a new stake in shares of ProAssurance during the 4th quarter worth about $202,000. Larson Financial Group LLC purchased a new stake in shares of ProAssurance during the 4th quarter worth about $223,000. Wolverine Trading LLC purchased a new stake in shares of ProAssurance during the 4th quarter worth about $247,000. Finally, Magnetar Financial LLC purchased a new stake in shares of ProAssurance during the 3rd quarter worth about $246,000. 82.69% of the stock is owned by institutional investors.

Shares of ProAssurance (NYSE:PRA) opened at $49.80 on Thursday. The stock has a market capitalization of $2,670.18, a PE ratio of 25.03 and a beta of 0.59. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.46 and a quick ratio of 0.46. ProAssurance has a one year low of $46.90 and a one year high of $63.45.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 18th. Stockholders of record on Thursday, March 29th will be paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date is Wednesday, March 28th. ProAssurance’s dividend payout ratio (DPR) is presently 62.31%.

WARNING: “$217.62 Million in Sales Expected for ProAssurance Co. (PRA) This Quarter” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.dailypolitical.com/2018/03/14/217-62-million-in-sales-expected-for-proassurance-co-pra-this-quarter.html.

About ProAssurance

ProAssurance Corporation (ProAssurance) is a holding company for property and casualty insurance companies. The Company provides professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, liability insurance for medical technology and life sciences risks, and workers’ compensation insurance.

Get a free copy of the Zacks research report on ProAssurance (PRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for ProAssurance (NYSE:PRA)

Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.